A recently-published analysis shows that provider pricing in the commercial market is essentially random, and there’s no correlation to quality
Practical solutions are coming and we explore 9 of them
"Tectonic Shifts" are happening as inflation, drug pricing battles, and cash-pay healthcare are colliding to redefine the industry’s next era.
I teamed up with two health policy experts to explore the bull and bear case.
